DaxibotulinumtoxinA for injection to treat moderate or severe glabellar lines: A randomized, multicenter, Phase III, double-blind, placebo-controlled trial in China
Journal of Plastic, Reconstructive & Aesthetic Surgery · 2024-12 · 99 · 67-75
DOI: 10.1016/j.bjps.2024.09.012 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Plastic, Reconstructive & Aesthetic Surgery, 2024-12. Verfasst von Yun Xie und 12 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Skin Aging, Forehead, Neuromuscular Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Tianjing Medical University General Hospital, Tianjing, China.
- West China Hospital, Sichuan University, Chengdu, China.
- Plastic Surgery Hospital, Chinese Academy of Medical Sciences, Beijing, China.
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Plastic Surgery of Beijing Hospital, National Center for Geriatrics, Chinese Academy of Medical Sciences Institute of Geriatrics, Beijing Hospital, Beijing, China.
Zitieren
APA
Xie, Y., Liu, Q., Li, L., Wang, B., Sun, J., Zhao, H., Guo, Q., Su, J., Fan, X., Wang, H., Ge, L., Wang, X., & Li, Q. (2024). DaxibotulinumtoxinA for injection to treat moderate or severe glabellar lines: A randomized, multicenter, Phase III, double-blind, placebo-controlled trial in China. Journal of Plastic, Reconstructive & Aesthetic Surgery, 99, 67-75. https://doi.org/10.1016/j.bjps.2024.09.012
Vancouver
Xie Y, Liu Q, Li L, Wang B, Sun J, Zhao H, et al. DaxibotulinumtoxinA for injection to treat moderate or severe glabellar lines: A randomized, multicenter, Phase III, double-blind, placebo-controlled trial in China. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2024;99:67-75. doi:10.1016/j.bjps.2024.09.012
BibTeX
@article{Xie2024,
author = {Xie, Yun and Liu, Quanzhong and Li, Li and Wang, Baoxi and Sun, Jiaming and Zhao, Hongyi and Guo, Qing and Su, Juan and Fan, Xiaojing and Wang, Hui and Ge, Lei and Wang, Xingli and Li, Qingfeng},
title = {DaxibotulinumtoxinA for injection to treat moderate or severe glabellar lines: A randomized, multicenter, Phase III, double-blind, placebo-controlled trial in China},
journal = {Journal of Plastic, Reconstructive & Aesthetic Surgery},
year = {2024},
volume = {99},
pages = {67--75},
doi = {10.1016/j.bjps.2024.09.012}
}
EUVIMED